First Manhattan’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,550
Closed -$169K 791
2024
Q1
$169K Hold
2,550
﹤0.01% 681
2023
Q4
$250K Hold
2,550
﹤0.01% 603
2023
Q3
$204K Hold
2,550
﹤0.01% 654
2023
Q2
$206K Hold
2,550
﹤0.01% 658
2023
Q1
$310K Hold
2,550
﹤0.01% 595
2022
Q4
$340K Hold
2,550
﹤0.01% 598
2022
Q3
$284K Hold
2,550
﹤0.01% 621
2022
Q2
$345K Sell
2,550
-16
-0.6% -$2.41K ﹤0.01% 605
2022
Q1
$427K Buy
2,566
+16
+0.6% +$3.04K ﹤0.01% 609
2021
Q4
$455K Hold
2,550
﹤0.01% 588
2021
Q3
$451K Hold
2,550
﹤0.01% 588
2021
Q2
$410K Hold
2,550
﹤0.01% 594
2021
Q1
$381K Hold
2,550
﹤0.01% 586
2020
Q4
$251K Buy
+2,550
New +$255K ﹤0.01% 625

Other funds holding CNXC

First Manhattan's CNXC Position: Q2 2024 in Review

First Manhattan sold out of Concentrix (CNXC) in Q2 2024, closing a stake of 2,550 shares — an estimated $169K sold.

First Manhattan first reported a position in CNXC in Q4 2020 and held it in 14 quarters. The position peaked at $455K in Q4 2021. 297 funds tracked by Wall St. Rank hold CNXC as of Q2 2024.

  • First Manhattan reported no remaining Concentrix position as of Q2 2024 after selling out during the quarter.
  • First Manhattan sold 2,550 Concentrix shares in Q2 2024, an estimated $169K.
  • First Manhattan first reported a position in Concentrix in Q4 2020 and held it in 14 quarters.
  • First Manhattan's Concentrix position peaked at $455K in Q4 2021.
  • 297 funds tracked by Wall St. Rank held Concentrix as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.